1. Home
  2. GAIA vs ATNM Comparison

GAIA vs ATNM Comparison

Compare GAIA & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

N/A

Current Price

$1.26

Market Cap

32.9M

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.54

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GAIA
ATNM
Founded
1988
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.9M
31.4M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
GAIA
ATNM
Price
$1.26
$1.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$3.38
★ $4.00
AVG Volume (30 Days)
95.5K
★ 242.6K
Earning Date
11-02-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 18.18
14.17
EPS
N/A
★ 0.71
Revenue
★ $4,500,000.00
$90,000.00
Revenue This Year
N/A
$38,788.89
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$2.16
Revenue Growth
★ 12.50
11.11
52 Week Low
$1.16
$0.74
52 Week High
$4.48
$1.72

Technical Indicators

Market Signals
Indicator
GAIA
ATNM
Relative Strength Index (RSI) 40.37 61.56
Support Level $1.18 $0.97
Resistance Level $1.47 $1.66
Average True Range (ATR) 0.07 0.14
MACD -0.01 0.00
Stochastic Oscillator 8.33 68.42

Price Performance

Historical Comparison
GAIA
ATNM

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: